AzTrials
AzTrials

Spinal Deformity With Sagittal ImbalancePhase 3PROFILENCT02730507

Surgical Treatment of Spinal Deformity With Sagittal Imbalance Using Patient-specific Rods: A Multicenter, Controlled, Double- Blind Randomized Trial: The PROFILE Study

A Phase 3 study testing Surgery with patient-specific rod and Conventional straight rod in people with Spinal Deformity With Sagittal Imbalance, run by Hospices Civils de Lyon.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Lumbar degenerative diseases (LDD) are an increasingly common condition affecting millions of patients worldwide. LDD can impact not only function, but can also become markedly disabling and cause severe chronic pain. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Spinal Deformity With Sagittal Imbalance
What is being tested?
Surgery with patient-specific rod and Conventional straight rod
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
73 participants
Where
No sites listed yet
Study dates
Oct 2016to 1 Mar 2022
Phase
Phase 3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • • Adult sagittal deformity of the spine defined as
  • a loss of lumbar lordosis versus the pelvic incidence (LL- PI) outside of the range of ±20°
  • PT>25° or SVA>50mm
  • Patients with functional impairment defined as an Oswestry Disability Index over 40/100
  • Spinal posterior fusion and instrumentation indicated for the patient
  • Surgery indicated for 4 or more lumbar levels: from T12 to S1
Show all 14Show fewer
  • Patients in whom an optimal correction of the sagittal profile is considered to be feasible according to the following criteria:
  • 10°≤ LL-PI≤10°
  • PT < 20°
  • SVA < 40mm.
  • Patients older or equal to 18 years
  • Patients able to sign an informed consent form
  • Patients able to fill out a self-administered questionnaire
  • Patient has to be the beneficiary of the social security system (order n° 2006-477 from April 26th 2006);

Who cannot join

  • • Coronal deformity without sagittal imbalance
  • Patients who required a vertebrectomy
  • Patients who do not required a bone graft or a bone fusion
  • Patient with congenital metabolic bone abnormalities
  • Patient with recent (less than 1month) lumbar vertebrae fracture
  • Patients with insufficient tissue coverage of the surgical site, an insufficient bone quality and quantity.
Show all 17Show fewer
  • History of an osteoporotic fracture, joint disease with fast evolution, bone resorption, osteopenia
  • Pathologic obesity (BMI > 40)
  • Patients with active or chronic infection, fever or leukocytosis.
  • Suspected or known allergy or intolerance to the medical device used and requesting a combination of different metals.
  • Patient with a medical contraindication to the material used or for which the use of the device could interfere with anatomical structures or expected physiological function.
  • Patients with ongoing treatment of any cancer or history of any cancer of less than 5 years
  • Chronic inflammatory disease
  • Women who are pregnant
  • Patients unable to understand the purpose of the trial or refusing to follow post-surgery instructions.
  • Participation to another trial
  • Patients under legal protection

About this study

Lumbar degenerative diseases (LDD) are an increasingly common condition affecting millions of patients worldwide. LDD can impact not only function, but can also become markedly disabling and cause severe chronic pain. Recent studies support the idea that analysis of sagittal balance is a crucial keypoint to optimize the management of lumbar degenerative diseases, especially when spinal instrumentation is intended.

The first treatment of these pathologies is a medical treatment (medications, physical therapy and exercise). Surgical treatment is frequently necessary if the symptoms worsen and is generally a posterior spinal fusion with instrumentation (screws, hooks and rods) and bone graft. Basic principle of the surgery is to realign the spine along the rod.

Read more

Despite documented techniques for surgical planning, it appears that a significant number of patients are ultimately under-corrected after surgery Realignment failure has not only been associated with poor functional outcome but also major complications, such as pseudoarthrosis and rod breakage, which often results in additional surgical procedures.

From a pragmatic point of view, there are two main reasons for realignment failure: poor surgical planning and poor execution. One of the assumptions is that perioperative manual bending of the rod may not always allow the surgeon to restore the sagittal parameters as intended.

A new concept of patient-specific rod (PSR) is now being proposed by a French manufacturer in order to enable an optimal correction and surgical stabilization of the spine. PSR are designed to fit with the patient's unique sagittal spine profile and with surgeons' surgical planning. However, no relevant clinical data is currently available to support the expected medical benefit of this new technology.

The objective of the study is therefore to carry out a study hypothesizing that the use of PSR could improve the percentage of patients whose sagittal profile is optimally corrected after spinal surgery, as well as the patient's quality of life.

Being tested
Surgery with patient-specific rod, Conventional straight rod

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Surgery with patient-specific rodDevice

    Bras A: PSRs must be used with the appropriate instrumentation designed by the same manufacturer. In order to minimize potential bias derived from using different spinal systems or reduction techniques, the posterior instrumentation must be the same (except the use of standard straight rod) in both groups. The surgical method to implement the PSR will be the same as the one to implement the conventional rod. Except for the bending procedure (patient specific rod or conventional rod with perioperative manual bending), the characteristics of implantable devices (biomaterial and diameter of the rod, design, type of screw, etc.) will be the same in each center.

  • Conventional straight rodDevice

    Bras B: The control group is composed of patients operated with standard straight rods, which are bent in the operating room by the surgeon. In order to minimize potential bias derived from using different spinal systems or reduction techniques, the posterior instrumentation used in the control group must be the same (except the use of PSRs) than the experimental group.

Study groups in NCT02730507
Study groupRoleWhat they receive
PSRExperimentalBras A : 167 patients in the experimental PSR group. Surgery with patient-specific rod, which are designed according to the preoperative surgical planning of the surgeon in collaboration with the manufacturer.
Receives: Device: Surgery with patient-specific rod
Conventional rodActive comparatorBras B: 167 patients in the experimental conventional rod group
Receives: Device: Conventional straight rod

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Proportion of patients whose sagittal profile is optimally corrected between both arms

    The primary end point is the proportion of patients whose sagittal profile is optimally corrected 12 months after a spine-surgery. The optimally corrected sagittal profile definition is based on the following composite criteria:

    • Lombar Lordosis (LL), measured between the superior endplate of L1 and the sacral plate, is equal to the Pelvic Incidence of the patient ± 10° (-10°≤ LL - Pelvic Incidence≤10°)
    • Pelvic Tilt is less than 20°
    • Sagittal Vertical Axis is less than 40mm. These 3 criteria will be measured and combined to define an optimal sagittal profile, by 3 members of an independent committee. Radiographic parameters will be measured on sagittal full-spine x-rays. The patient positioning will be standardized in order to obtain comparable and reproducible images. The positioning is standing both feet on the same alignment, 20-25 cm between the two feet, upper arm fingers tip on the clavicle.

    Measured: 12 months.

Secondary outcomes (3)
  1. Comparison of the proportion of patients whose sagittal profile is optimally corrected between both arms.

    Same outcome measure as the primary outcome but at different time of follow-up

    Measured: 3 months after surgery

  2. Comparison of the proportion of patients whose sagittal profile is optimally corrected between both arms.

    Same outcome measure as the primary outcome but at different time of follow-up

    Measured: 6 months after surgery

  3. Comparison of the proportion of patients whose sagittal profile is optimally corrected between both arms.

    Same outcome measure as the primary outcome but at different time of follow-up

    Measured: 24 months after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Apr 2016 (estimated)
  2. Study startOct 2016
  3. Primary completion1 Feb 2021
  4. Study completion1 Mar 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
73 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02730507
Sponsor's protocol ID
69HCL14-0444
Acronym
PROFILE
Status last verified
May 2022
First submitted
23 Mar 2016
Last updated
5 May 2022
Results posted
No
Data monitoring committee
Yes
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A Phase 3 study testing Surgery with patient-specific rod and Conventional straight rod in people with Spinal Deformity With Sagittal Imbalance, run by Hospices Civils de Lyon.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 14 inclusion and 17 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 May 2022. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Proportion of patients whose sagittal profile is optimally corrected between both arms (time frame: 12 months.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 May 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in